Malignant Urethral Neoplasm — Trials

Malignant Urethral Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

79 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 21
Recruiting: 7
Ph III recruiting: 1
Growth YoY: —
Industry share: 5%
Top sponsor: National Cancer Institute (NCI)
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (9)

clinicaltrialsPublishedShowing 1–5 of 5 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00942331	Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer	completed	Phase 3	506	National Cancer Institute (NCI)NIH	2	Jun 24, 2026	clinicaltrials
NCT00003376	Two-Drug Combination Chemotherapy Compared With Four-Drug Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium	completed	Phase 3	330	Eastern Cooperative Oncology GroupNETWORK	1	Jun 22, 2023